AVD American Vanguard

American Vanguard Secures Important Product Registration in Brazil

American Vanguard Corporation (NYSE: AVD) today announced that the company’s Brazilian subsidiary has been granted product registration for use of Counter® insecticide on soybeans in Brazil, the world’s largest agricultural market. Counter is a proven, market-leading soil insecticide that provides superior control of yield-damaging nematode infestation. Additionally, Counter is a selective nematicide, which allows it to be used effectively in conjunction with other products to achieve optimal pest control management.

Vitor Cunha, CEO of AMVAC-Brazil, commented: “Field results from farmers have shown that Counter is a unique product in terms of both technical performance and yield improvement. These attributes should translate into improved profitability for users of this premier product. AMVAC-Brazil and our distributor partners are prepared to supply and service the expanding demand for this key nematode control solution.”

Eric Wintemute, Chairman and CEO of American Vanguard, commented: “Counter is one of American Vanguard’s most important soil insecticide products and we are committed to expanding its use internationally. This registration in Brazil is very relevant to the adoption of our SIMPAS precision application technology. The economic and environmental benefits of this targeted deposition system will allow growers of soybean, corn, cotton, and sugarcane to generate greater profitability while providing crops with protection and nutrition in an environmentally sustainable manner.”

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection, turf and ornamentals management and public health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at .

The Company, from time to time, may discuss forward-looking information. All forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors are detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements represent the Company’s best judgment as of the date of this release.

EN
02/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on American Vanguard

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

American Vanguard Corp: 1 director

A director at American Vanguard Corp bought 12,000 shares at 5.970USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

 PRESS RELEASE

American Vanguard Withdraws Dacthal Registration

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD) today announced that, following its decision in April 2024 to voluntarily stop sales of Dacthal herbicide products, the Company has submitted to the Environmental Protection Agency (“EPA”) voluntary cancellation requests for all of its federal registrations of those products. Those registrations are currently the subject of an emergency suspension order that was issued by EPA on August 6, 2024. In connection with its action, the Company made the following statements. While the Company continues to question E...

 PRESS RELEASE

American Vanguard Reports Q2 2024 Results

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD) today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights – versus Second Quarter 2023: Net sales of $128.2 million v. $132.8 million Adjusted EBITDA1 of $6.2 million v. $10.7 million Earnings per share of $(0.42) v. $(0.04) First Half of 2024 Financial Highlights – versus First Half of 2023: Net sales of $263.4 million v. $257.7 million Adjusted EBITDA of $21.7 million v. $22.2 million Earnings per diluted share of $(0.36) v. $0...

 PRESS RELEASE

American Vanguard Schedules 2024 Second Quarter Earnings Release and C...

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD), today announced that it will report financial results for the second quarter ended June 30, 2024, on Thursday, August 8, 2024, after the close of the stock market. Tim Donelly, Acting CEO, David T. Johnson, VP, CFO and Treasurer, and Mark Bassett, Director will conduct a conference call focusing on operating performance and financial results at 4:30 pm ET / 1:30 pm PT on August 8, 2024. Interested parties may participate in the call by dialing 201-493-6744, please dial in 10 minutes before the scheduled start...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch